{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:20:53Z","timestamp":1760188853078},"reference-count":19,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2006,7,19]],"date-time":"2006-07-19T00:00:00Z","timestamp":1153267200000},"content-version":"vor","delay-in-days":7900,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Surgical Oncology"],"published-print":{"date-parts":[[1984,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>A case of veno\u2010occlusive disease of the liver with fatal outcome after dacarbazine (DTIC) therapy for melanoma is reported. There was a fulminant clinical course from start of symptoms until death. At autopsy the liver was enlarged and firm with signs of venous congestion. Small and medium\u2010sized hepatic veins were blocked by thrombosis. Eosinophilic infiltrations were found around the vessels. Published cases from the literature are reviewed and pertinent features discussed.<\/jats:p>","DOI":"10.1002\/jso.2930270415","type":"journal-article","created":{"date-parts":[[2007,2,20]],"date-time":"2007-02-20T10:11:47Z","timestamp":1171966307000},"page":"268-270","source":"Crossref","is-referenced-by-count":24,"title":["Veno\u2010occlusive liver disease after dacarbazine therapy (DTIC) for melanoma"],"prefix":"10.1002","volume":"27","author":[{"given":"Christian","family":"Erichsen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Per\u2010Ebbe","family":"J\u00f6nsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,7,19]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0305-7372(74)80020-4"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1159\/000224680"},{"key":"e_1_2_1_4_2","first-page":"343","article-title":"Symptoms of occult brain metastases initiated by systemic Dacarbazine (DTIC\u2010DOME) therapy in melanoma patients","volume":"6","author":"Hafstr\u00f6m Lo","year":"1980","journal-title":"Clin Oncol"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-86-4-508_2"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-88-4-575_2"},{"key":"e_1_2_1_7_2","first-page":"1863","article-title":"Fatal hepatotoxicity associated with AMSA therapy","volume":"66","author":"Appelbaum FR","year":"1982","journal-title":"Cancer Treat Rep"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00410649"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2008-1070640"},{"key":"e_1_2_1_10_2","first-page":"792","article-title":"Dacarbazin (DTIC)\u2010Therapie und Budd Chiari\u2010syndrome","volume":"122","author":"Balda B\u2010R","year":"1980","journal-title":"Munch Med Wochenschr"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19800515)45:10<2670::AID-CNCR2820451031>3.0.CO;2-L"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.282.6278.1744"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01476580"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(70)90254-6"},{"key":"e_1_2_1_15_2","first-page":"147","article-title":"N\u2010demythalation of the antineoplastic agent imidazole carboxamide by rats and man","volume":"30","author":"Skibber JL","year":"1970","journal-title":"Cancer Res"},{"key":"e_1_2_1_16_2","first-page":"149","article-title":"Mechanism of Action and Pharmacology Studies with DTIC (NSC\u201045388)","volume":"60","author":"Loo TL","year":"1976","journal-title":"Cancer Treat Rep"},{"key":"e_1_2_1_17_2","first-page":"27","article-title":"High dose DTIC in recurrent melanoma\u2010a controlled study","volume":"246","author":"J\u00f6nsson P\u2010E","year":"1983","journal-title":"Proc Int Congr Chemother"},{"key":"e_1_2_1_18_2","first-page":"165","article-title":"Clinical pharmacology of anticancer drugs","volume":"4","author":"Chabner BA","year":"1977","journal-title":"Semin Oncol"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-85-5-578"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197912)44:6<2324::AID-CNCR2820440648>3.0.CO;2-8"}],"container-title":["Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjso.2930270415","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jso.2930270415","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T12:53:43Z","timestamp":1697892823000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jso.2930270415"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1984,12]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1984,12]]}},"alternative-id":["10.1002\/jso.2930270415"],"URL":"https:\/\/doi.org\/10.1002\/jso.2930270415","archive":["Portico"],"relation":{},"ISSN":["0022-4790","1096-9098"],"issn-type":[{"value":"0022-4790","type":"print"},{"value":"1096-9098","type":"electronic"}],"subject":[],"published":{"date-parts":[[1984,12]]}}}